Biomedical Technology

BrainNow Medical Technology Limited

🌍 Official Website 🏢 HKSTP Source
48 Potential

Decision Maker

N/A
enquiry.marketing@hkstp.org
+852 2629 1818
5/F, Building 5E, 5 Science Park East Avenue, Hong Kong Science Park
Raw Description
The mission of BrainNow is to develop and commercialize clinically applicable computer-aided (CAD) software tools for diagnosis of dementia and other neurodegenerative diseases. Our product meets the requirements for accurate extraction of the relevant biomarkers, and enables their efficient use in clinical practice and clinical research, by providing a comprehensive visualization and analysis workflow that are related to values derived from large population-based imaging studies. || Product | The major functionality of our product is | 1) to support early detection of potential dementia from normal ageing-related cognitive decline; | 2) to support differential diagnosis to classify different types of dementia.

Strategic Analysis

Executive Brief

BrainNow Medical Technology Limited specializes in AI-driven Computer-Aided Diagnosis (CAD) for neurodegenerative diseases. Their core value proposition lies in the precision extraction of biomarkers from medical imaging data (MRI/PET) to provide early-stage detection and differential diagnosis of dementia. While primarily a software entity, their performance is fundamentally constrained by the Signal-to-Noise Ratio (SNR) of imaging hardware and the computational density of the AI inference engines required for real-time clinical workflows.

Strategic Fit & Lead Score

Lead Score: 48/100 (General Research / Engineering)

Why this Score? BrainNow is currently at the "Software/Algorithm" layer of the medical stack. However, to maintain a competitive advantage in "early detection," they require higher-fidelity data than standard MRI can provide. 6C’s Diamond technology offers a path toward Quantum Sensing (NV Centers) for next-generation neuro-imaging and Thermal Management for the high-performance computing (HPC) clusters that run their complex CAD algorithms.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Next-Gen Neuro-imaging SCD (Single Crystal) Diamond with NV Centers Enables Quantum Sensing (OPMs/MEG) with sensitivity levels orders of magnitude higher than cryogenic SQUIDs. Provides BrainNow with higher-resolution biomarker data for earlier dementia detection.
High-Performance AI Inference PCD (Polycrystalline) Heat Spreaders BrainNow's software requires heavy GPU/ASIC processing. 6C Diamond heat spreaders (thermal conductivity >2000 W/mK) prevent thermal throttling in the compact server units deployed in clinical environments.
Biochemical Sensing BDD (Boron Doped Diamond) Electrodes Development of electrochemical sensors for real-time detection of neurotransmitters (e.g., Dopamine, Serotonin) in liquid biopsies to validate BrainNow’s imaging-based biomarkers.
Edge Computing Hardware Custom MPCVD System Build If BrainNow expands into proprietary hardware "appliances" for hospitals, 6C can provide the MPCVD reactors to grow custom-doped diamond layers for specialized signal processing chips.

Engagement Hooks

  • Technical Question: "As BrainNow pushes the boundaries of early-stage biomarker extraction, are your algorithms hitting a ceiling due to the low sensitivity of current T-stage MRI hardware? Would access to Diamond NV-based quantum magnetic field sensors change your roadmap for sub-millimeter diagnostic accuracy?"
  • Value Statement: "6C Diamond Technology can bridge the gap between your advanced diagnostic software and the physical limits of medical sensors, ensuring your CAD tools process the highest-fidelity neuro-imaging data theoretically possible."